| CASMASCI | progen | BOC | 進(jìn)口現(xiàn)貨產(chǎn)品 | 胎牛血清 | 細(xì)胞培養(yǎng) | 提取試劑 | 轉(zhuǎn)染試劑 | 常規(guī)生化試劑 | ELISA試劑盒 | 抗體 | 細(xì)胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產(chǎn)品名稱:Anti-Mouse CD199 (CCR9) PerCP-eFluor® 710 (ebioCW-1.2) 100 ug
產(chǎn)品貨號(hào):eBioscience 46-1991-82
產(chǎn)品規(guī)格:100 ug
Anti-Mouse CD199 (CCR9) PerCP-eFluor® 710
Also known as: CCR-9
Clone: eBioCW-1.2 (CW-1.2)
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 46-1991
Cat. No. Size
46-1991-80 25 ug
46-1991-82 100 ug
Description: The eBioCW-1.2 monoclonal antibody reacts with mouse CCR9 (CD199), which is the receptor for thymus-expressed chemokine (TECK). CCR9 is a member of the G protein coupled receptor (GPCR) supergene family, and is involved in trafficking of T cell progenitors within the thymus. CCR9 expression during thymocyte development commences at the double-negative (DN) 3 stage (CD4-CD8-CD25+CD44-), peaks in the double-positive (DP) stage (CD4+CD8+CD25-CD44-), and is down-regulated in commited CD4+ or CD8+ single-positive (SP) thymoyctes. CCR9-deficient mice show a mild impairment in thymoycte development. In the periphery, CCR9 is thought to be expressed on naïve CD8+ T cells, but not on naïve CD4+ T cells.